Home > Insider Trading > Filing (0000950103-21-013102)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642545	Shockwave Medical Inc.	SWAV	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1404227	Evan Douglas Godshall	C/O Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara CA 95054	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-26	17,005	$3.42	115,364	No	4	M	Direct
Common Stock	Disposition	2020-08-26	17,005	$60.01	98,359	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-26	17,005	$0.00	17,005	$3.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
945,648		2027-05-09	No	4	M	Direct

Footnotes

On August 27, 2020, the reporting person filed a Form 4 which inadvertently did not include the exercise of an option and sale of shares reported in this Form 4 amendment. The number of shares reported as beneficially owned following this transaction reflects the number of shares owned on August 26, 2020, after giving effect to the transaction reported herein.
This exercise and all sale transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 9/6/2019.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $60.00 to $60.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.